Erisyon


Commercial developer of a single-molecule protein sequencing platform that uses selective fluorescent labeling, cyclic chemistry, high-throughput imaging, and database matching to identify and quantify peptides and proteins from ultra-low-input samples. The company spun out of University of Texas at Austin research and publishes peer-reviewed work and application notes describing the underlying methods and use cases.

Industries

biotechnology
health-care
information-technology-dbca

Nr. of Employees

small (1-50)

Erisyon

Austin, Texas, United States, North America


Products

Single-molecule protein sequencing instrument

A laboratory instrument and associated workflows that perform surface-immobilized, fluorescent-residue-based sequencing of peptides at single-molecule sensitivity and high throughput.


Services

Research collaboration and biomarker validation

Collaborative research and validation projects to translate single-molecule proteomics methods into biomarker discovery and validation (example: funded projects for Parkinson’s disease biomarker validation).

Technical literature and application notes

Provision of white papers and downloadable application notes demonstrating workflows and use cases (e.g., single-cell proteome cataloging, PTM mapping, antigen discovery).

Expertise Areas

  • Single-molecule proteomics
  • Biomarker discovery and validation
  • High-sensitivity clinical proteomics
  • Post-translational modification analysis
  • Show More (4)

Key Technologies

  • Single-molecule fluorescent sequencing (cyclic chemistry)
  • Selective fluorescent amino-acid labeling
  • Edman-like cyclic cleavage chemistry
  • Single-molecule fluorescence microscopy
  • Show More (4)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.